Bloodless Surgery in a Jehovah's Witness Patient with a 12.7-kg Uterine Leiomyosarcoma

Journal of Surgical Education

Volumn 64, Issue 4, 2007, Pages 212-219

  Nagarsheth, Nimesh P ^a   Shander, Aryeh ^b   Malovany, Robert ^c   Tzeng, Jausheng ^b   Ibrahim, Ibrahim ^b  

^a Englewood Hospital   (United States)

^b ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

anemia; bloodless surgery; Jehovah's Witness; Medical Knowledge; Patient Care; Systems Based Practice; uterine leiomyosarcoma

Indexed keywords

ERYTHROPOIETIN; FOLIC ACID; HEMOGLOBIN; IRON; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ANAMNESIS; ANEMIA; ARTICLE; ARTIFICIAL EMBOLISM; ARTIFICIAL VENTILATION; BLEEDING; CANCER INVASION; CASE REPORT; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DRUG DOSE REGIMEN; FEMALE; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTRAOPERATIVE PERIOD; JEHOVAH'S WITNESS; LEIOMYOSARCOMA; LONG TERM CARE; PELVIS; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TRACHEOSTOMY; TREATMENT REFUSAL; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE ARTERY; UTERUS SARCOMA;

BLOOD LOSS, SURGICAL; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INTRAOPERATIVE CARE; JEHOVAH'S WITNESSES; LEIOMYOSARCOMA; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; UTERINE NEOPLASMS;

EID: 34547739471     PISSN: 19317204     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsurg.2007.03.008     Document Type: Article

References (16)

1. Goodnough L.T., Shander A., and Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 43 (2003) 668-676
2. Nagarsheth N.P., Gupta A., Gretz H.F., Javidroozi M., Adeli R., and Shander A. Feasibility of bloodless surgery on a gynecologic oncology service. Int J Gynecol Cancer 16 (2006) 628
3. Sesti F., Ticconi C., Bonifacio S., and Piccione E. Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery. Gynecol Obstet Invest 54 (2002) 1-5
4. Stovall T.G. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer: implications for use in gynecologic surgery. J Reprod Med 46 (2001) 531-538
5. Connor J.P., Morris P.C., Alagoz T., Anderson B., Bottles K., and Buller R.E. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol 86 (1995) 373-378
6. Mirhashemi R., Averette H.E., Deepika K., et al. The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. Am J Obstet Gynecol 181 (1999) 1310-1315
7. Gyamfi C., and Berkowitz R.L. Responses by pregnant Jehovah's Witnesses on health care proxies. Obstet Gynecol 104 (2004) 541-544
8. PROCRIT (epoetin alfa) PRESCRIBING INFORMATION, Distributed by Ortho Biotech Products, L.P., Raritan, NJ. Rev'd January 2005. Available at: http://www.procrit.com/common/prescribing_information/PROCRIT/PDF/ProcritBooklet.pdf.
9. Fan D., Yarnall C., Parmat J.L., et al. Resection of a large atrial hemangioma using a bloodless surgical technique: a case report. Heart Surg Forum 10 (2007) E87-E89
10. Vedantham S., Goodwin S.C., McLucas B., and Mohr G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol 176 (1997) 938-948
11. Edelman M., Potter P., Mahaffey R.F., and Leidich R. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology 47 (1996) 179-181
12. Jabbour N., Gagandeep S., Peilin A.C., et al. Recombinant human coagulation factor VIIa in Jehovah's Witness patients undergoing liver transplantation. Am Surg 71 (2005) 175-179
13. Raivio P., Suojaranta-Ylinen R., and Kuitunen A.H. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 80 (2005) 66-71
14. Despotis G., Avidan M., and Lublin D.M. Off-label use of recombinant factor VIIa concentrates after cardiac surgery. Ann Thorac Surg 80 (2005) 3-5
15. Echt G., Jepson J., Steel J., et al. Treatment of uterine sarcomas. Cancer 66 1 (1990) 35-39
16. Dinh T.A., Oliva E.A., Fuller A.F., Lee H., and Goodman A.K. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol Oncol 92 (2004) 648-652